| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/03/2006 | EP1652534A2 Composition comprising coagulation factor VIII formulation, process for its preparation and use of a surfactant as stabilizer |
| 05/03/2006 | EP1652528A1 Activated carbon infusion solution, preparation method therefor and use thereof for the manufacture of drug for treating cancer |
| 05/03/2006 | EP1652524A1 Dry syrup containing loratadine |
| 05/03/2006 | EP1652523A1 Transdermal absorption preparation |
| 05/03/2006 | EP1652522A1 Sustained release tablet for oral use |
| 05/03/2006 | EP1652518A1 Pharmaceutical composition for sublingual administration |
| 05/03/2006 | EP1652517A1 Hyaluronic acid nanoparticles |
| 05/03/2006 | EP1652515A1 Process for producing drug ultramicroparticle and apparatus therefor |
| 05/03/2006 | EP1652514A1 At-use dispersed preparation |
| 05/03/2006 | EP1652508A1 Adhesive patch |
| 05/03/2006 | EP1651766A2 Targeted carrier fusions for delivery of chemotherapeutic agents |
| 05/03/2006 | EP1651566A1 Highly oil absorbing amorphous silica particles |
| 05/03/2006 | EP1651308A1 Implantable stimulation electrode with a coating for increasing tissue compatibility |
| 05/03/2006 | EP1651275A1 Use of recombinant or synthetic gelatin-like proteins as stabiliser in lyophilized pharmaceutical compositions |
| 05/03/2006 | EP1651274A1 Bioadhesive gel based on hydroxyethylcellulose |
| 05/03/2006 | EP1651273A1 Poly-4-hydroxybutyrate matrices for sustained drug delivery |
| 05/03/2006 | EP1651272A1 Use of recombinant or synthetic gelatin as a stabiliser in vaccines |
| 05/03/2006 | EP1651271A2 Compositions and methods for treating coronavirus infection and sars |
| 05/03/2006 | EP1651262A2 Process for preparing polysaccharide-protein conjugate vaccines |
| 05/03/2006 | EP1651261A2 Polysaccharide-protein conjugate vaccines |
| 05/03/2006 | EP1651259A2 Methods and compositions for producing antigenic responses |
| 05/03/2006 | EP1651249A1 Use of calcitonin in osteoarthritis |
| 05/03/2006 | EP1651233A2 Pharmaceutical composition |
| 05/03/2006 | EP1651218A1 Fexofenadine composition and process for preparing |
| 05/03/2006 | EP1651210A1 Dispersible formulation of an anti-inflammatory agent |
| 05/03/2006 | EP1651187A2 Sterile preparations of phospholipids and anti-inflammatory pharmaceuticals and methods for making and using same |
| 05/03/2006 | EP1651186A1 Macrolides containing oil-in-water emulsions |
| 05/03/2006 | EP1651185A1 Bioactive compositions comprising triazines |
| 05/03/2006 | EP1651184A1 Fast dissolving orally consumable films containing pharmaceutically active agents |
| 05/03/2006 | EP1651162A2 Improved cytotoxic agents comprising new maytansinoids |
| 05/03/2006 | EP1651136A2 Method for the preparation of controlled release formulations |
| 05/03/2006 | EP1651035A2 Compositions for encapsulation and controlled release |
| 05/03/2006 | EP1576150A4 Methods and compositions for increasing the efficacy of biologically-active ingredients |
| 05/03/2006 | EP1572665B1 1-n-phenylamino-1h-imidazole derivatives as aromatase inhibitors |
| 05/03/2006 | EP1572178B1 Treatment of mastalgia with 4-hydroxy tamoxifen |
| 05/03/2006 | EP1505930A4 Drug-delivery endovascular stent and method for treating restenosis |
| 05/03/2006 | EP1467724B1 Orodispersible pharmaceutical composition comprising agomelatine |
| 05/03/2006 | EP1425005B1 Pharmaceutical compostion comprising lumiracoxib |
| 05/03/2006 | EP1381358B1 Solid pharmaceutical composition comprising 4'-cyano-trifluoro-3-(4-fluorophenylsulphonyl) -2-hydroxy-2-methylpropiono- m toluidide and pvp |
| 05/03/2006 | EP1368006B1 Novel modified released formulation |
| 05/03/2006 | EP1335709B1 Capsule of cellulose derivatives such as hpmc containing benzimidazole derivatives such as omeprazole |
| 05/03/2006 | EP1317273B1 Use of il-6r/il-6 chimera in huntington's disease |
| 05/03/2006 | EP1312380B1 Aseptics |
| 05/03/2006 | EP1267829B1 Fast dissolving orally consumable films containing an ion exchange resin as a taste masking agent |
| 05/03/2006 | EP1235558B1 Compressed tablet composition comprising a nsaid |
| 05/03/2006 | EP1225809B1 Methods for stabilizing liquid nutritional products and products so stabilized |
| 05/03/2006 | EP1218023B8 Method for calming human beings using personal care compositions |
| 05/03/2006 | EP1210065B1 Cationic liposome delivery of taxanes to angiogenic blood vessels |
| 05/03/2006 | EP1209988B1 Cross-linked agent for generation of a long-lasting satiety effect and method for the production of the said |
| 05/03/2006 | EP1205190B1 Stable medicinal compositions for oral use using ferric oxides |
| 05/03/2006 | EP1185273B1 Antifungal oral composition containing itraconazole and process for preparing same |
| 05/03/2006 | EP1117822B1 Preparation of polyglucans by amylosucrase in the presence of a transferase |
| 05/03/2006 | EP1117726B1 Cosmetic products based on urethane(meth)acrylates containing siloxane groups and their free radical polymerisation products |
| 05/03/2006 | EP1104309B1 Co-lyophilized complex comprising a nucleic acid vector and a formulating agent |
| 05/03/2006 | EP1056459B1 Treatment of hiv infections |
| 05/03/2006 | EP0901368B1 Dermal penetration enhancers and drug delivery systems involving same |
| 05/03/2006 | EP0793500B1 Pharmaceutical compositions comprising nitric oxide-releasing polysaccharides |
| 05/03/2006 | CN1768047A Benzo[1,2,5]oxadiazoles and benzo [1,2,5]thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers. |
| 05/03/2006 | CN1767870A Otorhinological delivery device |
| 05/03/2006 | CN1767860A Methods and compositions for administering therapeutic and diagnostic agents |
| 05/03/2006 | CN1767858A Biologically active material conjugated with biocompatible polymer with 1:1 complex, preparation method thereof and pharmaceutical composition comprising the same |
| 05/03/2006 | CN1767857A Polymer-factor VIII moiety conjugates |
| 05/03/2006 | CN1767856A Pharmaceutical compositions for hepatitis C viral protease inhibitors |
| 05/03/2006 | CN1767850A Oral insulin composition and methods of making and using thereof |
| 05/03/2006 | CN1767849A Delivery system for drug and cell therapy |
| 05/03/2006 | CN1767836A Parenteral formulation of mycophenolic acid, a salt or prodrug thereof. |
| 05/03/2006 | CN1767831A Pharmaceutical formulations containing methylnaltrexone |
| 05/03/2006 | CN1767826A Pharmaceutical composition comprising an immunosuppressant for use in the treatment of skin diseases. |
| 05/03/2006 | CN1767825A Pharmaceutical composition containing platinum complex as active substance and method of manufacturing thereof |
| 05/03/2006 | CN1767824A Photostabilized topical formulations of KETOPROFEN |
| 05/03/2006 | CN1767822A Compositions and method for treating microbial and parasitic infections in cattle and other animals |
| 05/03/2006 | CN1767819A Solid pharmaceutical compositions comprising a S1P receptor agonist and a sugar alcohol |
| 05/03/2006 | CN1767815A Non-aqueous single phase vehicles and formulations utilizing such vehicles |
| 05/03/2006 | CN1767812A Osmotic delivery system and method for decreasing start-up times for osmotic delivery systems |
| 05/03/2006 | CN1767765A Skin preparation composition for external use |
| 05/03/2006 | CN1766034A Giant knotweed rhizome general anthraquinone and uses and formulation of acid ingredient of giant knotweed rhizome general anthraquinone |
| 05/03/2006 | CN1765419A Therapeutic infusion containing diphosphatase |
| 05/03/2006 | CN1765354A Three dimensional eye patch for treating eye wrinkles an its preparation method |
| 05/03/2006 | CN1254487C Reformed monoclonal antibody for resisting immunoglobulin homoeotype |
| 05/03/2006 | CN1254278C Medical ointment, film and tincture |
| 05/03/2006 | CN1254276C Matrix metalloproteinase inhibitors as targeting components in diagnostic agents |
| 05/03/2006 | CN1254271C Hybrid polypeptides with enhanced pharmacokinetic properties |
| 05/03/2006 | CN1254243C Pharmaceutical compositions comprising chelidonine or derivatives thereof |
| 05/03/2006 | CN1254237C Clear aqueous anaesthetic composition |
| 05/03/2006 | CN1254236C Lyophilized preparation of civeleth sodium |
| 05/03/2006 | CN1254234C Plasmid DNA (Lipogenes TM) and encapsulating therapeutica agent containing karyon-positioning signal /fusion-promoting peptide conjugate into targeted liposomes complex |
| 05/03/2006 | CN1254233C Aqueous dispersion comprising stable nanoparticles of a water-insoluble and an excipient like middle chain triglycerides (MCT) |
| 05/02/2006 | US7038037 Method for sequential support-bound synthesis of conjugated oligomeric compounds |
| 05/02/2006 | US7037928 Compositions of N-(methylethylaminocarbonyl)-4-(-3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides |
| 05/02/2006 | US7037907 Prodrug of an estradiol conjugated to a glucuronide sugar; 6-oxo-2-methoxyestradiol; 3-acetyl-6-oxo-2-methoxyestradiol; and 2-methoxyestradiol-6-hydrazone; angiogenesis inhibitor; antiinflammatory for asthma or rheumatoid arthritis |
| 05/02/2006 | US7037898 Tumor-activated prodrug compounds and treatment |
| 05/02/2006 | US7037889 Peptide and plurality of linked ligands that together form a water insoluble complex |
| 05/02/2006 | US7037718 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof |
| 05/02/2006 | US7037530 Mixture containing silica; blending, granulation |
| 05/02/2006 | US7037529 Spraying a suspension of microionized fenofibrate and polyvinylpyrrolidone onto an inert hydrosoluble carrier; immediate-release; improved dissolution |
| 05/02/2006 | US7037526 Film preparation for biphasic release of pharmacologically active or other substances |
| 05/02/2006 | US7037522 Nocturnal muscle enhancing composition and method |
| 05/02/2006 | US7037516 comprises nonionic surfactants such as polyoxyethylene-stearate for sustaining elevated milk production response in lactating mammals; improved bioavailability |
| 05/02/2006 | US7037499 Adjuvant for transcutaneous immunization |
| 05/02/2006 | US7037450 Production scale method of forming microparticles |